American Journal Of Cancer Research

American Journal Of Cancer Research

美国癌症研究杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《American Journal Of Cancer Research》是由E-CENTURY PUBLISHING CORP出版社于2011年创办的英文国际期刊(ISSN: 2156-6976,E-ISSN: 2156-6976),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA开放获取模式(OA占比0%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比88.76%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在347篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

American Journal Of Cancer Research该刊近年未被列入国际预警名单,年发文量约347篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 347 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 165 / 333

50.6

学科:ONCOLOGY SCIE Q3 177 / 333

47

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 106 / 322

67.2

学科:ONCOLOGY SCIE Q2 102 / 322

68.48

期刊发文

  • Therapeutic and prognostic value of repeat transurethral resection for high-grade Ta bladder cancer: a propensity score matching analysi

    Author: Zhang, Xiaoxi; Wang, Lei; Sun, Wenjun; Yang, Xiangli

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. -. DOI: 10.62347/VSXB5813

  • Study on the effects of statin use in immunotherapy for elderly cancer patients on immune-related adverse reactions and quality of lif

    Author: Zhang, Lei; Sui, Lili; Zhang, Qian; Qian, Liwen; Zhao, Jingxia; Chen, Xiaoyan

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 825-839. DOI: 10.62347/UXLW2031

  • Histone demethylase KDM4C activates HIF1α/VEGFA signaling through the costimulatory factor STAT3 in NSCLC (Vol 10, pg 491, 2020

    Author: Wu, Xiaowei; Deng, Yu; Zu, Yukun; Yin, Jin

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 947-949. DOI: 10.62347/ZHHG5906

  • Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective stud

    Author: Wu, Jing; Duan, Zhipei; Qian, Jing; Hu, Chengru; Chen, Chao; Li, Yan; Cao, Tinghua

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 920-936. DOI: 10.62347/QMNU5628

  • Analysis of influencing factors of recurrence after thoracoscopic resection in patients with Stage I a lung adenocarcinom

    Author: Wei, Rui-Shi; Ma, Jie; Li, Xin-Hua; Feng, Li; Chen, Gang; Yu, Jian-Rong

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 840-852. DOI: 10.62347/XOFY6189

  • Association between perioperative opioid consumption and postoperative outcomes in lung cancer surgery: evidence from a retrospective study with inflammatory and immune biomarker analysi

    Author: Li, Ruogen; Ma, Wuhua

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 866-881. DOI: 10.62347/EKNX6493

  • Clinical features and prognosis of patients with malignant tumors complicated by cerebral infarctio

    Author: Li, Haiyun; Wu, Xing; Yan, Xiaojie; Guo, Jiali; Gao, Zhongsheng

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 796-812. DOI: 10.62347/QFPJ9767

  • CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathwa

    Author: Sun, Yachao; Dai, Zhibing; Du, Junwei; Maihemuti, Maierdanjian; Ji, Suzhi; Jiang, Renbing

    Journal: AMERICAN JOURNAL OF CANCER RESEARCH. 2026; Vol. 16, Issue 3, pp. 966-984. DOI: 10.62347/YPDZ7241